Containment Is a Governance Decision: New Institutional Risk Review Published

Covernance Advisory.pdf

Download PDF • 1.97MB

Laparoscopic morcellation used in hysterectomy and myomectomy procedures remains an important tool in minimally invasive gynecologic surgery.

However, tissue fragmentation without effective containment may disseminate malignant or viable tissue within the peritoneal cavity, with potential implications for oncologic outcomes, benign disease burden, informed consent defensibility, and institutional liability exposure.

In an era of heightened scrutiny around tissue dissemination and

cancer risk, containment is not merely a surgical technique, it is a governance decision.

This advisory outlines:

• FDA prevalence data and regulatory context

• Practice variability and containment integrity considerations

• Documentation and VAC oversight implications

• Informed consent considerations

• Governance safeguards for hospital leadership

The publication also includes a practical one-page VAC and Risk Management Checklist designed to support internal policy review and documentation alignment.

The document is designed for Directors of Risk Management, Chief Quality Officers, VAC committees, and hospital counsel evaluating containment practices in light of evolving regulatory and litigation landscapes.

Download the full Institutional Risk Review and Governance Checklist below.

Covernance Advisory.pdf

Download PDF • 1.97MB